Jagsonpal Pharmaceuticals Debt

JAGSNPHARM   639.65  23.25  3.77%   
As of now, Jagsonpal Pharmaceuticals' Short and Long Term Debt Total is decreasing as compared to previous years. The Jagsonpal Pharmaceuticals' current Long Term Debt is estimated to increase to about 15.2 M, while Net Debt is forecasted to increase to (36.3 M). With a high degree of financial leverage come high-interest payments, which usually reduce Jagsonpal Pharmaceuticals' Earnings Per Share (EPS).
The Jagsonpal Pharmaceuticals' current Total Current Liabilities is estimated to increase to about 361.4 M, while Liabilities And Stockholders Equity is projected to decrease to under 1.7 B.
  
Check out the analysis of Jagsonpal Pharmaceuticals Fundamentals Over Time.

Jagsonpal Pharmaceuticals Debt to Cash Allocation

Jagsonpal Pharmaceuticals Limited has accumulated 89.41 M in total debt. Debt can assist Jagsonpal Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Jagsonpal Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Jagsonpal Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Jagsonpal to invest in growth at high rates of return. When we think about Jagsonpal Pharmaceuticals' use of debt, we should always consider it together with cash and equity.

Jagsonpal Pharmaceuticals Total Assets Over Time

Jagsonpal Pharmaceuticals Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Jagsonpal Pharmaceuticals' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Jagsonpal Pharmaceuticals, which in turn will lower the firm's financial flexibility.

Jagsonpal Pharmaceuticals Corporate Bonds Issued

Most Jagsonpal bonds can be classified according to their maturity, which is the date when Jagsonpal Pharmaceuticals Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Jagsonpal Short Long Term Debt Total

Short Long Term Debt Total

165.5 Million

As of now, Jagsonpal Pharmaceuticals' Short and Long Term Debt Total is decreasing as compared to previous years.

Understaning Jagsonpal Pharmaceuticals Use of Financial Leverage

Understanding the composition and structure of Jagsonpal Pharmaceuticals' debt gives an idea of how risky is the capital structure of the business and if it is worth investing in it. The degree of Jagsonpal Pharmaceuticals' financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
Last ReportedProjected for Next Year
Short and Long Term Debt Total89.4 M165.5 M
Net Debt-38.2 M-36.3 M
Short Term Debt13.8 M13.1 M
Long Term Debt14.4 M15.2 M
Long Term Debt Total60.3 M63.4 M
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Jagsonpal Stock

Jagsonpal Pharmaceuticals financial ratios help investors to determine whether Jagsonpal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jagsonpal with respect to the benefits of owning Jagsonpal Pharmaceuticals security.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.